CapEx News
Project News,Updates,Bids & Tenders for Consultants,EPC Contactors,Industrial Suppliers & Service Providers
Commercial production at the Sapigen Biologix vaccine plant in Odisha, the first such facility in the state, will commence by May this year, officials said. Chairman 5T and Nabin Odisha VK Pandian visited the facility.
The plant at the Biotech Park in Andharua will have the capacity to produce 2.4 crore doses of different vaccines per day. At full capacity, this facility will be the biggest vaccine-producing plant in the country, the Chief Minister’s Office (CMO) said in a statement.
Pandian visited all the sub-units and interacted with the management and employees. He instructed state government agencies to assist in the commissioning of the plant within the next 3 months.
It is expected to produce over 15 vaccines for various diseases, including cholera and malaria. The Rs 1,500-crore vaccine plant will create direct employment for 1,500 people, with most of them being local recruits, the CMO said.
The variety of vaccines produced in Bhubaneswar will be supplied to many parts of the world, it added.
Recent News
◉ MEIL secures Rs 13,000 crore nuclear reactor contract - Apr 25,2025◉ EV firm PURE unveils 5MWh grid storage solution - Apr 25,2025
◉ Uppercase to establish its luggage manufacturing plant in Nashik - Apr 25,2025
◉ Titagarh-BHEL collaborate on Rs 24,000 crore project - Apr 25,2025
◉ RITES secures Rs 28 crore Rail Infra contract from Mahanadi Coalfields - Apr 25,2025
◉ HG Infra Engineering qualifies for major battery storage project by GUVNL - Apr 25,2025
◉ Servotech wins 4.1 MW Rooftop solar project from Waltair Division, East Coast Railway - Apr 25,2025